PMDD is one of the most misunderstood conditions in women's health, partly because it is invisible outside the luteal phase and partly because the symptoms, severe mood disruption, rage, dissociation, and suicidal ideation, are so often attributed to personality or mental health conditions rather than to a cyclical hormonal trigger. Reddit's r/PMDD community has built one of the most detailed bodies of lived knowledge about this condition anywhere online, and tracking is at the centre of almost every recovery and diagnosis story.
"I didn't believe it was PMDD until I charted two cycles back to back"
This is the most repeated turning point in the r/PMDD community. Women describe years of being treated for depression, anxiety, or borderline personality disorder before someone, often another Reddit user, suggested charting symptoms against cycle day. The chart that comes back from two tracked cycles is frequently the first time the pattern becomes undeniable: symptoms arrive like clockwork after ovulation and vanish within 24 to 48 hours of bleeding starting.
The community is specific about what to track. Not just mood, but the functional impact of mood. Not just feeling sad, but unable to work, unable to parent, unable to leave the house. PMDD is a condition defined by functional impairment in the luteal phase, and tracking that impairment specifically, rather than just rating how bad the mood feels, produces the data that supports a clinical diagnosis.
A widely shared community practice is rating both symptom severity and functional impairment separately on a daily 1 to 10 scale. A 7 out of 10 mood disruption that still allows functioning is clinically different from a 7 out of 10 that results in calling in sick to work. The impairment rating is what PMDD diagnostic criteria actually assess, and it is what prospective tracking needs to capture.
What research says about PMDD diagnosis and cycle tracking
PMDD is classified in the DSM-5 as a depressive disorder with a specific cyclical pattern. Diagnosis requires prospective symptom charting for a minimum of two consecutive cycles confirming that symptoms are confined to the luteal phase and remit within a few days of menstruation onset. Retrospective reporting is explicitly insufficient for diagnosis because research consistently shows that people underestimate luteal symptoms when recalling them from a follicular vantage point.
The biological mechanism involves an abnormal sensitivity to normal hormonal fluctuations rather than abnormal hormone levels themselves. Women with PMDD typically have progesterone and estrogen levels within the normal range, but their neurological response to the luteal phase hormonal shift is significantly different from women without PMDD. This means standard hormone panels will not diagnose PMDD, and prospective symptom tracking is the only currently available diagnostic tool.
Research on PMDD treatment finds that luteal phase SSRIs, taken only during the luteal window rather than continuously, are effective for many patients. This makes precise cycle tracking directly relevant to treatment, because knowing exactly when the luteal phase begins determines when medication should start.